Navigation Links
Laboratory studies show promise for new multiple sclerosis treatment
Date:11/18/2010

Successfully treating and reversing the effects of multiple sclerosis, or MS, may one day be possible using a drug originally developed to treat chronic pain, according to Distinguished Professor Linda Watkins of the University of Colorado at Boulder.

Watkins and her colleagues in CU-Boulder's department of psychology and neuroscience discovered that a single injection of a compound called ATL313 -- an anti-inflammatory drug being developed to treat chronic pain -- stopped the progression of MS-caused paralysis in rats for weeks at a time.

Lisa Loram, a senior research associate who spearheaded the project in Watkins' laboratory, presented the findings at the Society for Neuroscience's annual meeting held in San Diego this week.

MS is an inflammatory disease where the body's immune system attacks a protective sheath called myelin that encompasses nerves in the spinal cord and brain. As the disease progresses, the myelin develops lesions, or scars, that cause permanent neurological problems.

"What happens now with MS drugs is they slow or stop the progression of MS, but they don't treat it," Watkins said. "They don't take people back to normal because the lesions caused by MS don't heal."

Watkins, Loram and their colleagues hope to use spinal cord and brain-imaging technology to extend their studies to determine if lesions are being healed in rats that received an ATL313 injection.

"If we have a drug that is able to heal these lesions, this treatment could be a major breakthrough in how we treat the symptoms of MS in the future," she said.

The new findings were quite a surprise to Watkins. The team had originally wanted to look at the drug's potential in treating pain associated with MS, because about 70 to 80 percent of MS patients suffer from chronic pain that is not treatable.

"What we had originally thought about this class of compounds is that they would calm down glial cells in the spi
'/>"/>

Contact: Linda Watkins
Linda.Watkins@colorado.edu
303-492-7034
University of Colorado at Boulder
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Lawrence Berkeley National Laboratory and OpenHelixTM Announce an Updated Free Tutorial Suite for VISTA: Tools for Comparative Genomics
2. Health Diagnostic Laboratory Inc. (HDL, Inc.) Launches Community Initiative, It Starts with the Heart
3. Bloomberg School of Public Health awarded $15 million for laboratory renovation and modernization
4. US Wellness, Inc. Receives National Recognition for Laboratory Excellence
5. Stirling Dental Laboratory, Experts in Emergency Denture Repair Service, Gives Back to Community
6. Amphora's PatentSafe Electronic Laboratory Notebook Fully Supported on the Apple iPad
7. Behavioral Laboratory Cracks the DNA Code of Happiness
8. Summit Medical Group Celebrates National Laboratory Professionals' Week
9. MUHC/McGill Ocular Pathology Laboratory celebrates a decade of progress
10. Slimming aid from the cell laboratory?
11. CAP Becomes IHE Laboratory Domain Sponsoring Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... Garden City, NY (PRWEB) September 30, 2014 ... , R.N., B.S.N., Clinical Manager Specialist, as a 2014 ... with this prestigious distinction for leadership in clinical care. ... the country, spanning virtually every industry and profession, the ... networking community with over 600,000 members and nearly 300 ...
(Date:9/29/2014)... Park Avenue Dental, a leading ... A. Sherman who has dedicated his career to providing ... announced its inclusion in the Patient Connect 365 dentist ... to private accounts so that they may manage online ... system also allows patients to request appointments, better communicate ...
(Date:9/29/2014)... According to the senior spokesman for Fecbek, the ... and was worn by a man, Ötzi the Iceman. ... the direction of using small ornamental purses—which evolved into ... a leading online supplier of fashion accessories, has released ... are fashionable. , For most men, they do ...
(Date:9/29/2014)... Chicago, IL (PRWEB) September 29, 2014 ... the option to review life insurance quotes from top ... search tool available now presents price exploration options at ... quotations are now presented inside of the formatted consumer ... insurers. The life plans that are offered to review ...
(Date:9/29/2014)... Humility of Mary Health Partners will offer SlimDown, ... and Velma Davis Family YMCA in Boardman and St. Joe’s ... manage their weight by making lifestyle changes with regard to ... to 6:30 p.m. Wednesdays at the YMCA, 2045 McClurg Road, ... the Mall (next to the rear entrance to Sears) beginning ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Sarah Shiermeister, Clinical Manager Specialist at Gentiva Health Services, a 2014 Professional Woman of the Year 2Health News:Florida’s Park Avenue Dental Now Part of Intuitive Patient Connect 365 Dentist Search Portal 2Health News:Florida’s Park Avenue Dental Now Part of Intuitive Patient Connect 365 Dentist Search Portal 3Health News:Life Insurance Quotes for Chicago Residents Now Quoted Using New Agency Tool Online 2Health News:Humility of Mary Health Partners Offers SlimDown Classes 2
... those at risk, expert says, , FRIDAY, Aug. 14 (HealthDay ... bones in older men, says a new study. , The ... 65 and older who had their sex hormone levels measured ... with low levels of estradiol or high levels of sex ...
... , , TUSTIN, Calif., Aug. ... company with major operations in China, announced today it has filed ... Exchange Act of 1934, as amended, with the Securities and Exchange ... the second quarter ended June 30, 2009. This filing provides for ...
... , WESTON, Fla., Aug. 14 Kidz-Med, ... Sheets: ASFX), is announcing a change in the distribution channels of ... Recently, the Company has learned of Walgreens, intent to cut many ... including the Kidz-Med Thermofocus. To the Company,s knowledge, this decision is ...
... , , Additional 28 ... WASHINGTON, Aug. 14 Today, Secretary of Veterans Affairs Eric ... other assistance in 28 additional communities across the country where the ... , , "VA is committed to providing ...
... , , EDINA, Minn., Aug. 14 ... Assure blood glucose meter test strips do not use GDH-PQQ (glucose ... blood glucose results in patients who are using certain therapeutic products. ... of products use a glucose-specific enzyme and can, therefore, distinguish between ...
... , , WHITE PLAINS, N.Y., ... Next Generation Nutrition Grants, donating a total of $120,000 to four non-profit ... families. , , (Photo: http://www.newsc ... 7 67 ) , , Through ...
Cached Medicine News:Health News:Sex Hormone Levels Linked to Fractures in Men 2Health News:AMDL Inc. Files Notification of Late Filing for Form 10-Q 2Health News:Child Health and Safety Product Distribution Channel Changes 2Health News:Secretary Shinseki Announces Expansion of Counseling for Combat Veterans 2Health News:ARKRAY Statement Regarding U.S. Food and Drug Administration's Public Health Notification: Potentially Fatal Errors With GDH-PQQ Glucose Monitoring Technology 2Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 2Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 3Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 4Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 5Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 6Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 7
(Date:9/29/2014)... , Sept. 29, 2014 Adaptive ... Next Generation Sequencing to profile the adaptive immune ... Scientific Advisory Board to provide strategic and clinical ... suite of assays in the diagnosis and monitoring ... focus of the SAB will be to support ...
(Date:9/29/2014)... BOSTON , Sept. 29, 2014  Arisaph ... on discovery and development of novel therapies for ... has been awarded a phase II Small Business ... I grant, both from the National Cancer Institute ... II award of $1,066,916 supports research and development ...
(Date:9/29/2014)... TEL-AVIV, Israel , Sept. 29, 2014 /PRNewswire/ ... ) ("Galmed"), a clinical-stage biopharmaceutical company focused on ... medication for the treatment of liver diseases and ... EndoPAT™ devices and accessories from Itamar Medical Ltd. ... company whose technology has been cleared by the ...
Breaking Medicine Technology:Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 2Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 3Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 2Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 3Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 4Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 2Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 3
... Hospira, Inc. (NYSE: HSP ... announced positive results from a Phase I U.S. clinical ... renal (kidney) dysfunction who have anemia. Hospira,s trial met ... and distribution in the body, for Hospira,s EPO and ...
... 6, 2011 Omthera Pharmaceuticals, Inc., a privately-held emerging ... and Chief Executive Officer, will present at the Rodman ... 2011 at 2:25pm ET at the Waldorf Astoria Hotel ... Pharmaceuticals, Inc. Founded in 2008, Omthera ...
Cached Medicine Technology:Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 2Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 3
... FH system uses a ... infrastructure operating in ... communication of patient information. ... of up to 640 ...
Spacelabs offers an approach that allows your telemetry and step-down units to configure systems to meet their telemetry requirements. Our modular telemetry system data are integrated into the depart...
ISI Alumi-Hand is the safe, sterile, ready-to-use ,surgical hand immobilizer....
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
Medicine Products: